Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Biology Open|June 6, 2025
A feed-forward loop between Toll/NF-κB and Rac1 promotes epithelial to mesenchymal transition of Ras-oncogenic hindgut enterocytes in DrosophilaMyrofora Panagi, Alexandros Galaras, Pantelis Hatzis, et al.
Theranostics|September 28, 2022
Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectivenessMyrofora Panagi, Pampina Pilavaki, Anastasia Constantinidou, et al.
Oncotarget|July 11, 2019
Constructing personalized longitudinal holo'omes of colon cancer-prone humans and their modeling in flies and miceMyrofora Panagi, Konstantina Georgila, Aristides G Eliopoulos, et al.
Cancers|April 30, 2021
The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic OpportunitiesChristiana M Neophytou, Myrofora Panagi, Triantafyllos Stylianopoulos, et al.
Cell Reports. Medicine|June 29, 2024
Modulating cancer mechanopathology to restore vascular function and enhance immunotherapyFotios Mpekris, Myrofora Panagi, Antonia Charalambous, et al.
Frontiers in Oncology|January 23, 2023
Exploring the landscape of immunotherapy approaches in sarcomasPampina Pilavaki, Myrofora Panagi, Samia Arifi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 10, 2022
Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapyFotios Mpekris, Chrysovalantis Voutouri, Myrofora Panagi, et al.
Neoplasia (New York, N.Y.)|March 23, 2024
A synergistic approach for modulating the tumor microenvironment to enhance nano-immunotherapy in sarcomasFotios Mpekris, Myrofora Panagi, Antonia Charalambous, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 15, 2025
Sonopermeation combined with stroma normalization enables complete cure using nano-immunotherapy in murine breast tumorsConstantina Neophytou, Antonia Charalambous, Chrysovalantis Voutouri, et al.
Molecular Cancer Therapeutics|June 28, 2024
Tumor Microenvironment Reprogramming Improves Nanomedicine-Based Chemo-Immunotherapy in SarcomasAntonia Charalambous, Fotios Mpekris, Myrofora Panagi, et al.
Pageof 3